XXII — 22nd Century Group, Inc.

XXII closed at $0.1977 (-8.34%) on Oct 23, 2026. Active shelf registration (S-3, Jun 2026). Float: 133.5K shares. Latest SEC filing: 424B5 on Oct 23, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for XXII in the TickerWise workspace.

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

Company profile

• Sector: Consumer Defensive
• Industry: Tobacco
• Country: US
• Exchange: NASDAQ
• Employees: 56
• Website: https://www.xxiicentury.com

Latest SEC filings for XXII

• 2026-10-23424B5
• 2026-10-238-K
• 2026-09-018-K
• 2026-08-1410-Q
• 2026-08-14424B3
• 2026-08-138-K
• 2026-08-058-K
• 2026-07-028-K
• 2026-06-26424B3
• 2026-06-25EFFECT

Related companies

• PM — Philip Morris International Inc.
• BTI — British American Tobacco p.l.c.
• MO — Altria Group, Inc.
• RLX — RLX Technology Inc.
• TPB — Turning Point Brands, Inc.
• UVV — Universal Corporation
• ISPR — Ispire Technology Inc.
• GNLN — Greenlane Holdings, Inc.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.